Activation and sensitization of meningeal nociceptors by PACAP-38: implications for migraine headache
Brain · 05.03.2026 · 149 (3) · 897-907
DOI: 10.1093/brain/awaf284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 06.08.2025. Verfasst von Rune Häckert Christensen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen 2100, Denmark. Hauptthemen laut MEDLINE: Pituitary Adenylate Cyclase-Activating Polypeptide, Nociceptors, Migraine Disorders, Meninges. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lundbeck Foundation, NINDS NIH HHS, NINDS.
Abstract (Originalsprache)
Emerging evidence implicates pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38) in migraine and other headache disorders. Systemic infusion of PACAP-38 induces migraine headache in people with migraine and mild headache in healthy adults. However, the precise mechanism and site of action remain poorly characterized. To address this gap, we assessed whether PACAP-38 elicits headache by activating meningeal nociceptors. In vivo single-unit electrophysiological recordings were obtained from C- and Aδ-meningeal nociceptors in the trigeminal ganglion of anaesthetized male and female rats. Spontaneous firing rates and mechanical responses to dural indentation with von Frey filaments were recorded before and for 4 h after a 20-min intracarotid infusion of PACAP-38 (1 µg/ml/kg, 10 µg/ml/kg and 100 µg/ml/kg) or vehicle (isotonic saline). At the human-equivalent dose (10 µg/ml/kg), PACAP-38 activated 15 of 30 (50%) neurons, compared with none after vehicle (P < 0.01). Activation rates did not differ between C-fibres (7 of 17; 41%) and Aδ-fibres (8 of 13; 61.5%). The lowest dose of PACAP-38 (1 µg/ml/kg) activated 3 of 9 (33%) neurons, whereas the highest dose (100 µg/ml/kg) activated all four tested neurons, including two C-fibres and two Aδ-fibres. These results suggest that PACAP-38 induces headache through peripheral activation of meningeal nociceptors rather than exerting direct central effects within the spinal trigeminal nucleus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen 2100, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.
- Harvard Medical School, Boston, MA 02115, USA.
- Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
ORCID-Profile: Håkan Ashina, Rami Burstein
Förderung
- Lundbeck Foundation
- NINDS NIH HHS
- NINDS
Zitieren
APA
Christensen, R. H., Strassman, A., Ashina, M., Ashina, H., & Burstein, R. (2026). Activation and sensitization of meningeal nociceptors by PACAP-38: implications for migraine headache. Brain, 149(3), 897-907. https://doi.org/10.1093/brain/awaf284
Vancouver
Christensen RH, Strassman A, Ashina M, Ashina H, Burstein R. Activation and sensitization of meningeal nociceptors by PACAP-38: implications for migraine headache. Brain. 2026;149(3):897-907. doi:10.1093/brain/awaf284
BibTeX
@article{Christensen2026,
author = {Christensen, Rune Häckert and Strassman, Andrew and Ashina, Messoud and Ashina, Håkan and Burstein, Rami},
title = {Activation and sensitization of meningeal nociceptors by PACAP-38: implications for migraine headache},
journal = {Brain},
year = {2026},
volume = {149},
number = {3},
pages = {897--907},
doi = {10.1093/brain/awaf284}
}
EUVIMED